Angle Share Discussion Threads

[purchaseatthetop] 19/10/2022 14:53

Jackdaw. That is not me! It is a clone avatar missing a “t”. But I agree with the view that AGL will recover strongly.

[jackdaw4243] 19/10/2022 14:51

Purchase

Added a few based on your prediction let's hope Santa is kind.

[antonagis] 19/10/2022 14:12

Pikey Gypsy LIAM on his lunch break after yet more failed interviews at the job centre. HALLAND in the bedsit he shares with Liam all depressed after being rejected for the janitors role at McDonald’s. Poor lads.

[1liam] 19/10/2022 13:39

Prefabricated rampers Amaretto/Purchaseatthetop on the other board trying to get mug punters to buy. Boy they're getting upset and desperate.Jefferies and the American markets selling off, gearing down continues.Buy price 20p if you're prepared to wait a little longer.

[purchaseathetop] 19/10/2022 13:13

Well said Amaretto. I will continue to buy here. This should be £1+ per share by year end.

[amaretto1] 19/10/2022 13:05

But because your so stupid and heading for the poor house ...You will continue to hold EUA Liam ..This is called the 85 percent club .. they are coveted by spread bet companies and the like ....It will be a great shame to have lost your repetitive banter by Xmas ..But this is what separates the wheat from the chaff in investing ...U r definitely the latter .... RIP Liam

[purchaseathetop] 19/10/2022 12:51

Bought another several thousand between 49.5-49.75p after reading Amaretto post this morning. A must buy and certainly hold IMO of course. I doubt there are many other shares globally with this potential for increase.

[mrkeysersoze] 19/10/2022 12:46

Liquid Biopsy Market Size to grow by USD 1.74 Bn by 2026 with 55% of the growth to originate from North America

See below link




Mr K.

[antonagis] 19/10/2022 12:07

That post from PURCHASE made me LOL. Obviously he’s referring to his avatar and fellow serial ramper AMARETTO.

[purchaseatthetop] 19/10/2022 11:47

Every time my clone avatar posts it is a good idea to buy for AGL I agree.

[1liam] 19/10/2022 08:09

This has dropped from 160p last year and continues to drop, that's a fact.Investors adage - Sell on rumours buy on facts. Come back at 20p

[amaretto1] 19/10/2022 07:16

i too read it ....About 10 percent of it was correct. It was a pretty articulate post ... exactly what paid Shorters are paid to put out .... I'm been serious here. Is IP address will be telling and who he's linked to ...I'm pretty confident it's to a financial entity...... AGL have Never been in a better position... it's at a serious pivotal infection point !! HOLD OR ADD

[asdb9] 19/10/2022 00:15

Well Yelrom has sold out and moved on, so we won't be seeing any more posts from him.Or will we??? Place your bets

[sicilian_kan] 19/10/2022 00:06

Here is one more from Yelrom's only other post he has ever made on Angle:

"No doubt another fund raising will rear it's ugly head once this one runs out and AN can negotiate another ridiculous 1 million fee to the City parasites. On what planet was that fee justified for what must have been a couple of phone calls to drum up investment in a company with a newly won FDA approval."

Really, you think that you get Baillie Gifford to drop £12m of their hard earned investee cash, buying Angle at 80p per share in a placing in one of the toughest biotech markets ever, with just a couple of phone calls from a so called parasitical broker??

[sicilian_kan] 18/10/2022 23:56

Personally, I thought yelrom's post a little hysterical and quite different from the balanced posts he says that he appreciates:

"so it's an absolute indictment of Newland and the finance and pharma industries that this product is being brought to market so slowly and indeed if at all". [if indeed it is at all being brought to the market, really??, of course it is being brought to the market and it already has contracts including 2x $1m+ contracts, one surprising the market because it was obtained before they even had FDA approval]

"Rather than letting the company go to what looks like now an inevitable cheap distressed buyout in a couple of years to either Americans or private equity it would be better to gift the technology to our own NHS". [really, seriously, with 20+ companies negotiating with Angle for contracts, and talks with Abbott at the detailed discussion stage and progressing "very well", you just give it away to the NHS]

"The latest RNS asserts we have enough runway until H2 2024. So to me this immediately implies little or no revenue from the already FDA approved product for two years at least. So the plan is to obtain more research results for other cancers and FDA approvals whilst we have no commercialisation for two years of the already granted one. Is this what talks with numerous parties results in. Newland could be talking to 20 or 200 companies, it's academic if that's all it is, talk." [I do not know why there appears to be surprise about the revenue trajectory. It has been in the broker notes for years. For example, Jefferies currently predict: 2022 £2.0m revenue, 2023 £4.8m revenue, 2024 £14.3m revenue, 2025 £42.6m revenue, 2026 £81.1m revenue. Plus revenues rising rapidly every year to get to £81.1m within 4 years is not all talk].

I could carry on, but the point is made.

[jimboau] 18/10/2022 22:42

Fantastic post yelrom, the best on here for quite a while!

[henley2] 18/10/2022 22:06

Yelrom, congratulations on your post.
It hits the nail right on the head as to what is going wrong here.
I would encourage you to forward it to Andrew Holder at Angle Investor Relations.

[purchaseathetop] 18/10/2022 20:36

I will continue to buy all the way down and recommend this to those looking for a huge medium to long term return.

[purchaseathetop] 18/10/2022 20:35

Cannot believe I was able to buy around 5000 of these in a few transactions between 49-50.50p. Lowers my average. Now waiting for inevitable rise when the deals happen. Newland definitely the man to take us forward. This should be well over £1 by Xmas.

[purchaseatthetop] 18/10/2022 19:28

Just ignore my clone avatar above.